SHR-2906
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 16, 2025
A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
(clinicaltrials.gov)
- P1 | N=84 | Not yet recruiting | Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
New P1 trial • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1